



<?xml version="1.0" encoding="ISO-8859-1"?>

<!DOCTYPE rss PUBLIC "-//Netscape Communications//DTD RSS 0.91//EN"
 "http://my.netscape.com/publish/formats/rss-0.91.dtd">

<rss version="0.91">

<channel>
<title>Indian Biotech Observer</title>
<link>http://www.indianbiotechobserver.com</link>
<description>Indian Biotech Observer - Admin Section</description>
<language>en-us</language>

<item>
<title>NRDC launches online database of biotech technologies</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1454</link>
<description>Recently National Research Development Corporation has launched online database of all biotech technologies developed by various national CSIR and ICAR laboratories for technoentrepreneurs .&lt;br&gt;&lt;br&gt;It includes not only biotech technologies but also technologies from various sectors.&lt;br&gt;&lt;br&gt;Interested peoples can go to --- &lt;a href=&quot;http://www.techbazar.in/&quot;&gt;www.techbazar.in&lt;/a&gt;.&lt;br&gt;</description>
</item>

<item>
<title>Central govt allocates Rs 1800 cr for innovative R&amp;amp;D in biotech sector</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1453</link>
<description>Central govt allocates Rs 1800 cr for innovative R&amp;amp;D in biotech sector.</description>
</item>

<item>
<title>Novo Nordisk collaborates with VLST Corporation</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1452</link>
<description>&lt;div&gt;Novo Nordisk and VLST Corporation, a Seattle-based biotechnology company announced that the companies have entered into an exclusive, worldwide collaboration agreement to develop therapeutic targets utilising VLST's technology platform in the fields of autoimmune and inflammatory disorders.&lt;/div&gt;</description>
</item>

<item>
<title>DBT allocates Rs 350 cr under Biotechnology Industry Partnership Programme</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1450</link>
<description>&lt;div&gt;The Department of Biotechnology (DBT) has allocated Rs 350 crore under the Biotechnology Industry Partnership Programme (BIPP).&lt;/div&gt;&lt;br&gt;</description>
</item>

<item>
<title>Lotus starts large multi-centre phase-III trial involving 1100 subjects</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1449</link>
<description>&lt;div&gt;Lotus Labs, a subsidiary of Iceland based Actavis, has commenced a large dermatology clinical end point trial in 35 sites involving 1,100 patients.&lt;/div&gt;</description>
</item>

<item>
<title>Life sciences sector continues to attract investments</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1448</link>
<description>&lt;div&gt;Financial investors and private equity (PE) firms continue to invest in India&amp;rsquo;s life sciences sector, even as they have tightened their purse strings for investments in other sectors like retail, information technology and back-office firms.&lt;/div&gt;</description>
</item>

<item>
<title>DBT, DST launches programme to support vaccine research units</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1447</link>
<description>&lt;div&gt;The Department of Biotechnology and Department of Science Technology have jointly announced a Core Vaccine Research Units (CVRU) programme to boost up the vaccine research activities in the country.&lt;/div&gt;</description>
</item>

<item>
<title>DBT creates special Cell &amp;#039;BIRAP&amp;#039; to oversee R&amp;amp;D projects</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1446</link>
<description>&lt;div&gt;To oversee the research and development projects across the country launched by it, the Department of Biotechnology (DBT) has created a new body, Biotechnology Industry Research &amp;amp; Development Assistance Programme (BIRAP) Cell.&lt;/div&gt;</description>
</item>

<item>
<title>Global generics prescription sales growth slide down to 3.6%: IMS</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1445</link>
<description>&lt;div&gt;Global prescription sales growth of generics drugs slowed to 3.6 per cent in the twelve months ending September 2008, down from 11.4 per cent in 2007, according to a new report by IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries.&lt;/div&gt;&lt;br&gt;</description>
</item>

<item>
<title>Health ministry calls for suggestions on draft application form</title>
<link>http://www.indianbiotechobserver.com/modules.php?name=News&amp;file=article&amp;sid=1444</link>
<description>The Ministry of Health &amp;amp; Family Welfare has released a draft application form for provisional registration of clinical institutions in India under the Clinical Establishments (Registration and Regulation) Bill, 2007, seeking suggestions from the stake holders before finalising the format.</description>
</item>

</channel>
</rss>
